ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials for Breast Cancer

Find clinical trials for breast cancer. Discover research opportunities and treatment options in your area.

1514 Active Trials Found

Showing 1514 trials on this page

Page 4 of 76

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

NCT ID: NCT07055854

This clinical trial is testing a program called Mindful After Cancer (MAC), designed to help women who have had breast or gynecologic cancers and are experiencing challenges with sexual health or b...

Not yet recruiting
Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Philadelphia, Pennsylvania, United States +1 more

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

NCT ID: NCT04174742

This clinical trial is looking at how pain levels reported by women undergoing treatment for breast cancer might differ based on age. Specifically, the study will compare whether younger women (age...

Recruiting
Type: observational Locations: Charlotte, North Carolina, United States, Winston Salem, North Carolina, United States

Erector Spinae Block vs. Placebo Block Study

NCT ID: NCT03978780

This clinical trial is looking at a method called the Erector Spinae Block, which is a type of nerve block used during breast cancer surgery. The goal is to see if this technique can help patients ...

Not yet recruiting
Phase: NA Type: interventional Locations: Toronto, Ontario, Canada

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

NCT ID: NCT05394285

This clinical trial is studying a medication called hetrombopag olamine, which is being tested to see how well it works and how safe it is for women with advanced breast cancer who are experiencing...

Recruiting
Phase: PHASE2 Type: interventional Locations: Zhengzhou, Henan, China

PET/CT for Trop2 ADC Response Evaluation Cancers

NCT ID: NCT07046689

This clinical trial is studying a new way to see how well a specific breast cancer treatment is working. The treatment targets a protein called Trop2 found on some breast cancer cells, using a spec...

Recruiting
Type: observational Locations: Xiamen, Fujian, China

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

NCT ID: NCT06914440

This clinical trial is studying a new treatment approach for women with a specific type of breast cancer known as HR-positive and HER2-negative breast cancer, which is at an advanced stage (Stage I...

Recruiting
Phase: PHASE2 Type: interventional Locations: Xi'an, , China, Xi'an, Shannxi Province, China

Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent

NCT ID: NCT06351865

This clinical trial is looking at how well patients can report any complications they experience after breast surgery, specifically for those with early invasive breast cancer. It aims to see if us...

Recruiting
Type: observational Locations: Portsmouth, Hampshire, United Kingdom

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

NCT ID: NCT05797545

This clinical trial is studying how well two different imaging techniques—breast ultrasound and MRI—detect breast cancer in women who have a history of the disease. The researchers want to see whic...

Recruiting
Phase: NA Type: interventional Locations: Busan, Busanjin Gu, Korea, Republic Of, Seoul, Gangnam Gu, Korea, Republic Of +2 more

ATEMPT 2.0: Adjuvant T-DM1 vs TH

NCT ID: NCT04893109

The ATEMPT 2.0 clinical trial is investigating how effective two different treatments are for patients with newly diagnosed HER2-positive breast cancer after surgery. The trial compares a medicatio...

Recruiting
Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Durham, North Carolina, United States +55 more

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT ID: NCT07067138

This clinical trial is studying a new way to find better treatment options for people with advanced breast cancer that is hard to treat. Researchers are testing a computer program called ENLIGHT, w...

Not yet recruiting
Phase: NA Type: interventional Locations: Bethesda, Maryland, United States

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

NCT ID: NCT06227728

This clinical trial is looking at how changes in certain blood markers can help doctors predict how well patients with advanced-stage cancer respond to a type of treatment called immunotherapy. Spe...

Recruiting
Type: observational Locations: Ho Chi Minh City, , Vietnam, Ho Chi Minh City, Hồ Chí Minh, Vietnam +1 more

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

NCT ID: NCT05232916

This clinical trial is studying a new treatment called GLSI-100 for patients with HER2/neu positive breast cancer who are at high risk of their cancer returning. The trial aims to see how effective...

Recruiting
Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Los Angeles, California, United States +242 more

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

NCT ID: NCT06253520

This clinical trial is exploring a new treatment for adults with advanced cancers that have spread, such as colorectal, breast, lung, gastrointestinal, ovarian, and genitourinary cancers. The goal ...

Recruiting
Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

NCT ID: NCT06364267

This clinical trial is comparing two medications, low-dose exemestane (also called babyexe) and low-dose tamoxifen (known as babytam), to see how they affect the quality of life in post-menopausal ...

Not yet recruiting
Phase: PHASE2 Type: interventional Locations: Genova, , Italy

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting
Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +20 more

A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

NCT ID: NCT06738966

This clinical trial is investigating a new drug called BL0175 for treating postmenopausal women with certain types of advanced cancer, specifically breast, ovarian, and endometrial cancers that are...

Recruiting
Phase: PHASE1 Type: interventional Locations: Changchun, Jilin, China, Sydney, New South Wales, Australia +1 more

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

NCT ID: NCT06797635

This clinical trial, called HERTHENA-Breast-03, is exploring new treatment options for patients with high-risk early-stage breast cancer, specifically those with triple-negative breast cancer (TNBC...

Recruiting
Phase: PHASE2 Type: interventional Locations: Nashville, Tennessee, United States, Skokie, Illinois, United States +4 more

Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

NCT ID: NCT03995082

This clinical trial is focused on understanding how breast cancer patients feel about their treatment and care by using a tool called Patient Reported Outcome Measures (PROMs). PROMs are surveys th...

Recruiting
Phase: NA Type: interventional Locations: Denver, Colorado, United States, Lone Tree, Colorado, United States +1 more

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

NCT ID: NCT06896162

The PROGRESS clinical trial is exploring how a specialized approach to cancer treatment, known as precision medicine, can help patients with advanced solid tumors, including breast, lung, colorecta...

Recruiting
Phase: NA Type: interventional Locations: Chapel Hill, North Carolina, United States

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

NCT ID: NCT05000294

This clinical trial is testing a new treatment approach for certain types of cancer that are usually hard to treat with existing immunotherapies, which are therapies designed to help the immune sys...

Recruiting
Phase: PHASE1 Type: interventional Locations: Gainesville, Florida, United States

Related Conditions

Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials → Heart Failure View clinical trials →
Search All Trials Browse All Conditions